Impaired cardiovascular-immune interactions in preeclampsia

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Preeclampsia is a dangerous pregnancy complication that can be life-threatening for the mother and fetus. Currently there is no treatment. We are investigating the mother's immune system in essential maternal cardiovascular adaptations necessary for sustain a healthy pregnancy, and how it influences early events of embryo implantation and placental development. This research will improve our understanding of the maternal immune system in pregnancy, and may lead to new treatments options.

Funded Activity Details

Start Date: 01-01-2015

End Date: 01-01-2018

Funding Scheme: Early Career Fellowships

Funding Amount: $343,243.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Obstetrics and Gynaecology

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

cardiovascular disease | endothelial function | pre-eclampsia | regulatory T cells | reproductive immunology